Juno Therapeutics, Inc. (JUNO)

Oncology Corporate Profile

Stock Performance

30.0500
0.3600

HQ Location

307 Westlake Avenue N., Suite 300
Seattle, WA 98109

Company Description

Juno is focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Founded on the vision that the use of human T cells as therapeutics will drive one of the next important phases in medicine, we are developing cell-based cancer immunotherapies based on our chimeric antigen receptor (CAR) and high-affinity T cell receptor (TCR) technologies to genetically engineer T cells to recognize and kill cancer cells. We have shown compelling evidence of tumor shrinkage in clinical trials using multiple cell-based product candidates to address refractory B-cell lymphomas and leukemias. Longer term, Juno aims to develop our cell-based platform to include additional product candidates to address a broad range of cancers and human diseases.

Website: http://junotherapeutics.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
JCAR015CD19 inhibitorNon-Hodgkin's Lymphoma (NHL)II
JTCR016WT-1 inhibitorAcute Myelogenous Leukemia (AML)I
JCAR023L1CAM antibodyNeuroblastomaI
JTCR016WT-1 inhibitorNon Small Cell Lung Cancer (NSCLC)I
JCAR017CD19 inhibitorNon-Hodgkin's Lymphoma (NHL)I
JCAR017CD19 inhibitorPediatric Acute Lymphocytic Leukemia (ALL)I
JCAR018CD-22 inhibitorChronic Lymphocytic Leukemia (CLL)

View additional information on product candidates here »

Source: http://junotherapeutics.com/

Recent News Headlines

7/24/2017 06:19 pm

7/24/2017 06:19 pm

7/24/2017 06:19 pm

7/24/2017 06:19 pm

7/24/2017 06:19 pm

7/21/2017 06:18 am

7/21/2017 06:18 am

7/21/2017 06:18 am

7/18/2017 12:18 pm

7/18/2017 12:18 pm

7/18/2017 12:18 pm

7/18/2017 06:18 am

7/15/2017 12:18 pm

7/15/2017 12:18 pm

7/15/2017 12:18 pm

7/14/2017 12:18 pm

7/13/2017 06:18 am

7/12/2017 12:18 pm

7/9/2017 06:18 am

7/7/2017 06:18 am

7/6/2017 12:18 pm

6/30/2017 06:18 am

6/29/2017 12:18 pm

6/26/2017 12:18 pm

6/26/2017 06:18 am